Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

CLF065 for Chronic Pouchitis — Stella

Home/Pouchitis/CLF065 for Chronic Pouchitis

View on ClinicalTrials.gov

Recruiting

Back to Pouchitis trials

CLF065 for Chronic Pouchitis

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Phillip Fleshner, M.D. Inc, Los Angeles, California

Key details

Phase

Safety & dosing

Sponsor

Calibr, a division of Scripps Research

Enrollment target

~20 participants

Started

March 2026

Primary completion

March 2027

Age range

18 Years – 80 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.